Jeff W. Meeusen, Ph.D.

Location

Contact

SUMMARY

Jeff W. Meeusen, Ph.D., researches advancing the field of laboratory medicine through innovative approaches and collaborative efforts. His work primarily targets the development and implementation of new diagnostic assays and technologies to improve people's care. Dr. Meeusen is particularly interested in studying biomarkers for cardiovascular conditions, metabolic illnesses and other chronic conditions. His approach involves integrating cutting-edge laboratory techniques with clinical insights to improve diagnostic accuracy and individuals' outcomes.

Focus areas

• Lipids and lipoproteins. Dr. Meeusen's primary research focus is on understanding the role of lipids and lipoproteins in cardiovascular conditions. He studies the mechanisms by which these molecules contribute to the development and progression of atherosclerosis and other cardiovascular conditions. The goal is to identify new biomarkers and therapeutic targets to improve people's outcomes.
• Calculations in laboratory medicine. Dr. Meeusen's work on calculated lab values strives to enhance the accuracy and clinical use of these measurements. For low-density lipoprotein cholesterol, the research involves developing and validating new methods for calculating low-density lipoprotein cholesterol levels. These levels are crucial for assessing cardiovascular risk. For estimated glomerular filtration rate, the focus is on improving the estimation of kidney function. This is particularly important in people with chronic kidney conditions to better guide treatment decisions.
• Remote lab collection techniques. Dr. Meeusen researches innovative methods for collecting lab samples remotely, which may improve access to diagnostic testing for individuals. The goal is to develop reliable and user-friendly techniques that maintain the accuracy and integrity of the samples. These techniques expand the reach of laboratory medicine and improve people's care by servicing individuals at home.

Significance to patient care

Dr. Meeusen's research helps improve individual's care by finding better ways to collect, test and report crucial laboratory values for managing chronic conditions. The MI-Heart Ceramides blood test combines several lipids into a simple 12-point scale of risk. This test is available through Mayo Clinic Laboratories. It helps healthcare professionals and patients talk and plan for treatment. He also works on improving the calculations used for common lab tests such as those for cholesterol and kidney function. This allows for improved accuracy without the need to fast or account for social factors in a lab report. Finally, by improving methods for collecting lab samples remotely, individuals may get tested without leaving their homes. This makes healthcare more accessible and convenient for everyone.